LA Billionaire's Biotech Firm Inks With Alexandria

Alexandria Real Estate Equities strikes again. This time, in the former Novartis space in its Nautilus campus.

NantKwest Inc inked a deal for 44,700 SF at 3530 John Hopkins Ct, part of the complex once used by Merck & Co and Novartis, according to filings with the SEC. Alexandria, which bought the Nautilus project in 2012 and renovated into a life science complex, inked the sizable deal with NantKwest this past summer for both office and R&D uses, according to docs.

This deal is part of what Alexandria's Dan Ryan recently called the best leasing quarter in 20 years. The firm also secured a build-to-suit with Eli Lilly at its Campus Point Drive project. This deal for NantKwest comes on the heels of that biotech's recent IPO, which secured a market cap of more than $2B. NantKwest, controlled by LA billionaire Patrick Soon-Shiong (here), makes cancer immunotherapy medicines.

Continue reading this story with a free account

Log in or register
Sign up for more articles like this
Subscribe to Bisnow's San Diego Newsletters
Related Stories

Broward Lures Office Tenants Away From Miami-Dade

ISIF Commits €100M To IPUT's €500M Office Development Pipeline

Morningstar Releases New Details On Over 350K SF In Q3 Office Leases

Weil Gotshal Wind-Down Leaves 830K SF Hole In America's Office Market

'Distress Is Finally Trading': Investors Chasing Big Discounts On Boston Office

Office Recovery Moving Faster Than Expected, CoStar Finds

How Microsoft, Coca-Cola And Amazon Are Adapting Their Offices For AI Age

Hof Wonen Acquires 251 Social Rental Houses In New Mixed-Use Project In The Hague

Related, Oxford Land Tenant For Top Floors Of 70 Hudson Yards

BXP Execs See Better Returns In Building Offices Than Buying Them

Downtown Office Tower Sells At Foreclosure Auction For $260M

Houston's Office Woes Are Getting Too Expensive To Fix